Literature DB >> 2582256

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

P T Francis, A M Palmer, N R Sims, D M Bowen, A N Davison, M M Esiri, D Neary, J S Snowden, G K Wilcock.   

Abstract

Multiple neurotransmitter deficits found in recent autopsy studies of patients with Alzheimer's disease may militate against the success of "simple cholinergic replacement" as treatment. To study acetylcholine synthesis, we measured the incorporation of radiolabeled glucose into the transmitter in temporal-cortex specimens obtained at diagnostic craniotomy in 17 young patients with Alzheimer's disease. Synthesis of acetylcholine was significantly correlated with cognitive impairment. These results are consistent with the view that the deficit in the presynaptic cholinergic system is a relatively early change in the development of the clinical features of the disease. Other alterations in noradrenergic cells, some cortical neurons, postsynaptic cortical receptors, and possibly serotoninergic cells may not be closely associated with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582256     DOI: 10.1056/NEJM198507043130102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  38 in total

Review 1.  Traumatic brain injury as a risk factor for Alzheimer's disease: a review.

Authors:  T C Lye; E A Shores
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

2.  Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.

Authors:  N Yamazaki; K Kato; E Kurihara; A Nagaoka
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors.

Authors:  J Winkler; G A Ramirez; L J Thal; J J Waite
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 4.  Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.

Authors:  Panos Theofilas; Sara Dunlop; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Aluminum and the pathogenesis of dialysis dementia.

Authors:  A I Arieff
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

Review 6.  The basis for behavioural disturbances in dementia.

Authors:  M M Esiri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

7.  Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.

Authors:  F P Zemlan
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Neuropharmacological correction of cognitive processes disrupted by extirpation of the AI-AII and Ep fields in cats.

Authors:  E I Mukhin
Journal:  Neurosci Behav Physiol       Date:  1996 Nov-Dec

9.  Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.

Authors:  B J Sahakian; A M Owen; N J Morant; S A Eagger; S Boddington; L Crayton; H A Crockford; M Crooks; K Hill; R Levy
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats.

Authors:  K Kawashima; A Sato; M Yoshizawa; T Fujii; K Fujimoto; T Suzuki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.